British Journal of Clinical Pharmacology

Research and Education
pp. 1-3(3)
Author: Ritter, J. M.

Computerised Pill Counting - how will technology support research into medication adherence?
pp. 4-5(2)
Author: Coleman, Jamie J.

The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived?
pp. 6-19(14)
Authors: Newsome, Barrett W.; Ernstoff, Marc S.

Respirable dose delivery of fluticasone propionate from a small valved holding chamber, a compact breath actuated integrated vortex device and a metered dose inhaler
pp. 20-26(7)
Authors: Nair, Arun; Menzies, Daniel; Barnes, Martyn; Burns, Patricia; McFarlane, Lesley; Lipworth, Brian J.

Evidence of the in vivo esterification of budesonide in human airways
pp. 27-35(9)
Authors: van den Brink, Karen I. Maassen; Boorsma, Martin; Staal-van den Brekel, A. Jeske; Edsbäcker, Staffam; Wouters, Emiel F.; Thorsson, Lars

Sitagliptin, an dipeptidyl peptidase-4 inhibitor, does not alter the pharmacokinetics of the sulphonylurea, glyburide, in healthy subjects
pp. 36-42(7)
Authors: Mistry, Goutam C.; Bergman, Arthur J.; Zheng, Wei; Hreniuk, David; Zinny, Miguel A.; Gottesdiener, Keith M.; Wagner, John A.; Herman, Gary A.; Ruddy, Marcella

Glucagon is absorbed from the rectum but does not hasten recovery from hypoglycaemia in patients with type 1 diabetes
pp. 43-49(7)
Authors: Parker, David R.; Braatvedt, Geoffrey D.; Bargiota, Alexandra; Newrick, Paul G.; Brown, Stephen; Gamble, Gregory; Corrall, Roger J. M.

Variability in the pharmacokinetics of intravenous busulphan given as a single daily dose to paediatric blood or marrow transplant recipients
pp. 50-59(10)
Authors: Nath, Christa E.; Earl, John W.; Pati, Nalini; Stephen, Katherine; Shaw, Peter J.

Pain relief model for a COX-2 inhibitor in patients with postoperative dental pain
pp. 60-70(11)
Authors: Rohatagi, Shashank; Kastrissios, Helen; Sasahara, Kunihiro; Truitt, Kenneth; Moberly, James B.; Wada, Russell; Salazar, Daniel E.

The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men
pp. 71-75(5)
Authors: Rolan, Paul; Sargentini-Maier, Maria Laura; Pigeolet, Etienne; Stockis, Armel

Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look
pp. 76-81(6)
Authors: Opatrny, Lucie; Delaney, J. A. `Chris'; Suissa, Samy

Amiodarone-induced pulmonary toxicity
pp. 82-87(6)
Authors: Ernawati, Desak Ketut; Stafford, Leanne; Hughes, Jeffery David

Candidate mechanisms for capecitabine-related hand-foot syndrome
pp. 88-95(8)
Authors: Milano, Gérard; Etienne-Grimaldi, Marie-Christine; Mari, Mireille; Lassalle, Sandra; Formento, Jean-Louis; Francoual, Mireille; Lacour, Jean-Philippe; Hofman, Paul

Absence of respiratory effects with ivabradine in patients with asthma
pp. 96-101(6)
Authors: Babu, K. Suresh; Gadzik, Frantisek; Holgate, Stephen T.

A new formulation of tolevamer, a novel nonantibiotic polymer, is safe and well-tolerated in healthy volunteers: a randomized phase I trial
pp. 102-109(8)
Authors: Peppe, Jennifer; Porzio, Andrew; Davidson, David M.

Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10-year follow-up of outcome
pp. 110-116(7)
Authors: Wei, Li; Fahey, Tom; MacDonald, Thomas M.

Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women
pp. 117-127(11)
Authors: Blouin, Julie; Dragomir, Alice; Moride, Yola; Ste-Marie, Louis-Georges; Fernandes, Julio Cesar; Perreault, Sylvie

Undergraduate preparation for prescribing: the views of 2413 UK medical students and recent graduates
pp. 128-134(7)
Authors: Heaton, Amy; Webb, David J.; Maxwell, Simon R. J.

Measuring learning from the TRC pharmacology E-Learning program
pp. 135-141(7)
Authors: Franson, Kari L.; Dubois, Eline A.; de Kam, Marieke L.; Cohen, Adam F.

A signal of increased risk of hypoglycaemia with angiotensin receptor blockers caused by confounding
pp. 142-145(4)
Authors: Grégoire, Fleur; Pariente, Antoine; Fourrier-Reglat, Annie; Haramburu, Françoise; Bégaud, Bernard; Moore, Nicholas

The Dutch model for clinical pharmacology: collaboration between physician- and pharmacist-clinical pharmacologists
pp. 146-147(2)
Authors: Schellens, Jan H. M.; Grouls, René; Guchelaar, Henk Jan; Touw, Daan J.; Rongen, Gerard A.; de Boer, Anton; Van Bortel, Luc M.

Haemoptysis associated with gatifloxacin in a 27 year old male asthmatic - a case report
pp. 148-149(2)
Authors: Gupta, Varun; Rizvi, Waseem; Dar, Khurshid A.; Bhargava, Rakesh; Kumar, Anil

Late-onset celecoxib-induced combined hepato-nephrotoxicity
pp. 150-151(2)
Authors: Tabibian, James H.; Tabibian, Neshan; Kaufman, David M.

An unusual systemic reaction associated with topical salicylic acid in a paediatric patient
pp. 152-153(2)
Authors: Loraschi, Anna; Marelli, Rosaria; Crema, Francesca; Lecchini, Sergio; Cosentino, Marco

Impact of CYP3A5 genetic polymorphism on pharmacokinetics of tacrolimus in healthy Japanese subjects
pp. 154-155(2)
Authors: Suzuki, Yoshiharu; Homma, Masato; Doki, Kosuke; Itagaki, Fumio; Kohda, Yukinao

Is using Nazi research to condemn homeopathy ethical or scientific?
pp. 156-157(2)
Authors: Milgrom, Lionel R.; Moebius, Suse

Reply to Milgrom and Moebius
pp. 157-158(2)
Author: Ernst, Edzard

Translation Section
pp. 159-167(9)